Delamanid for Extensively Drug-Resistant Tuberculosis

2015 
Therapeutic options for extensively drug-resistant tuberculosis infection are limited. In this post-hoc analysis, a new drug, delamanid, shows some activity in the treatment of XDR-TB.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    3
    References
    46
    Citations
    NaN
    KQI
    []